We are studying the development of fibtogenic lesions in the lungs of rats exposed briedly to an aerosol of chrysotile asbestos fibers. This model of asbestosis has enabled us to establish very early cellular events at the specifc locations where interstitial fib& will develop. These sites, the fust alveolar duct bifurcations, are where the fibers are hitially deposited and where macrophages fmt accumulate. In the niques to show that these macrophages exhibit strong localization of transforming growth factor-b. In the adjacent de-studiesptesentedhere, ~usedi"t~10hkt0chemicaltec.h-
Introduction
Exposure to chrysotile asbestos results in asbestosis, an interstitial lung disease characterized by progressive deposition of connective tissue matrix (Selikoff and Lee, 1978) . A number of animal models for this disease have been studied in which the asbestos exposure has been achieved either by inhalation (Brody and Overby, 1989;  Pinkerton et al., 1984; Barry et al., 1983;  Davis et al., 1978; Wagner et al., 1974) or by intratracheal instillation (Begin et al., 1981 (Begin et al., ,1983 Craighead et al., 1982;  Schoenberger et al., 1982) . Introduction of asbestos fibers into the lung by either method results in interstitial fibrosis at the junction of the terminal bronchioles and alveolar ducts as is the case in human asbestosis (Begin et al., 1983;  Craighead et al., 1982;  Selikoff and Lee, 1978;  Wagner et al., 1974; Wagner, 1965) . Previous work from our laboratory has employed a rat model of chrysotile asbestos-induced fibrosis to address basic mechanisms of fiber inhalation, deposition, and consequent development of asbestosis (McGavran et al., 1990; Chang et al., 1988; Brody et al., 1981) . The fibers initially deposit at the first bifurcations ofthe alveolar ducts distal to the t e d bronchioles (Brody and Roe, 1983) . Within 12-24 hr after a single orposure to asbestos, alveolar macrophages accumulate at these sites of fiber deposition actin. Such studies essential in furthclling OW mdermand-&:1061-1070, 1994) (Warheit et al., 1984 (Warheit et al., ,1985 (Warheit et al., ,1986 Brody et al., 1981) . Interstitial fibrogenesis begins within 48 hr post exposure and progresses at these sites through 1 month after a single 1-hr arposurr to asbestos (Chang et al., 1988) . This fibrosis is characterized by a progressive increase in interstitial cells and surrounding extracellular matrix (Chang et al.. 1988 ).
Although it is now clear that the pattem of deposition of inhaled asbestos fibers is consistent with the resulting fibrosis, the basic cellular and biochemical mechanisms that mediate the process are not clearly defiied. Alveolar macrophages are thought to play a central role in lung defense and disease through release of secretory products (Nathan, 1987) including cytokines and growth factors, and macrophages interact with surrounding cells in a variety of situations (Sibille and Reynolds, 1990) . It has been shown that alveolar macrophages from asbestos-exposed rats secrete a variety ofchemotactic and growth factors, among them a chemotactic factor for alveolar macrophages (Kagan et al., 1983) and a chemotactic factor for interstitial fibroblasts ( Kagan et al., 1986) .
Alveolar macrophages from asbestos-exposed animals also secrete fibronectin (Davies and Erdogdu, 1989 ). a chemotactic factor for fibroblasts that also appears to play a role in fibroblast replication (Bitterman et al., 1983) . The production of growth factors by activated alveolar macrophages and the resulting effects of these factors on mesenchymal cells are likely to be important links between macrophage recruitment and interstitial fibrosis.
"forming growth factor-b (Em) is a multifhnctional cytokine capable of regulating cell growth and differentiation as well as stimulating production of extracellular matrix (Fine and PERDUJi, BRODY . . , 1987; Postlethwaite et al., 1987; Ignotz and Massague, 1986) . It has been suggested that TGFP plays an important role in bleomycin-induced pulmonary fibrosis, where it is localized almost exclusiVely in alveolar macrophages when total lung content of TGFP is at a maximum (Khalil et al., 1989) . TGFP may also play an important role in idiopathic pulmonary fibrosis, where it has been localized in association with bronchiolar epithelial cells and associated extracellular matrix . In addition to stimulation of extracellular matrix production, TGFD stimulates proliferation of certain types of mesenchymal cells (Moses et al., 1987) and can be chemotactic for fibroblasts (Roberts and Spom, 1990) . TGFB also enhances the expression of a-smooth muscle actin in cultured myocytes and smooth muscle cells (Bjorkerud, 1991; Parker et al., 1990) . Expression of a-smooth muscle actin increases in bleomycin-induced fibrosis of rat lung (Mitchell et al., 1989) . Our model of asbestos-induced lung injury allows observation of very early events at the specific locations where interstitial fibrosis will develop (Brody and Overby, 1989 ). To gain a better understanding of the cellular mechanisms leading to fibrosis, we have investigated the localization of TGFP in lungs of adult rats exposed to an asbestos aerosol. Our results indicate that TGFB is localized in alveolar macrophages accumulating at alveolar duct bifurcations. We also show a concomitant increase in fibronectin at these sites. In addition, morphometric analysis of a-smooth mukle actin demonstrates a significant increase in this protein within alveolar duct bifurcations after the asbestos exposure.
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Materials and Methods
Exposure and Tissue Collection. Adult male CD white rats were exposed to an aerosol of chrysotile asbestos (10 mg/m3 respirable mass) in open cages contained within inhalation chambers for a period of 5 hr on each of3 consecutive days as previously described (Warheit et al., 1984 (Warheit et al., ,1985 . Unexposed control rats were kept for similar periods in cages exposed to room air. After recovery periods of 1 or 14 days after the third day of exposure, animals were anesthetized by IP injection of sodium pentobarbital (1 ml of a 1% solution). The trachea was exposed and a small incision made before insertion of a 19-gauge catheter. After securing the catheter, the lungs were perfused with fresh periodate-lysine-paraformaldehyde (McLEan and Nakane, 1974) at a pressure of 15 cm H20 for 15 min. After perfusion, the trachea was clamped, the cannula was removed, and the lungs were removed from the chest cavity and placed in fresh fixative for 24 hr at 4". Tissue blocks were consistently chosen from the mid-section of the left lung (a site chosen to be consistent with previous studies from this lab) and processed for routine histology. Five-pm paraffin sections were placed on Am-coated glass slides (Henderson, 1989 ) and stored at room temperature (RT) before processing for immunocytochemistry.
Immunocytochemistry. Sections were deparaffinized and subjected to the following schedule for immunocytochemical localization of E F P : (a) treatment with 0.01% trypsin in 0.05M %is-HC1, pH 7.8, for 15 min at 37'C; (b) blocking of endogenous peroxidase activity with 3% aqueous H202 for 20 min at RT; (c) blocking of nonspecific protein binding with 10% normal rabbit serum for 30 min at RT; (d) primary antibody, incubation with chicken anti-porcine 'Em1 (R & D Systems; Minneapolis, MN) for 1 hr at RT; (e) secondary antibody, incubation with biotinylated rabbit anti-chicken IgG F(ab)2 fragment (Accurate; Westbury, NY) for 30 min at RT; (f) incubation with ABC.Elite (avidin-biotin complex) (Vector Labs; Burlingame, CA) for 30 min at RT; and (9) treatment with 0.5 mg/ml diaminobenzidinc (Vector) in 0.05 M %is-buffered saline containing 0.1% H202 for 5 min at RT. The same schedule was followed for fibronectin localization except for the following changes: (a) nonspecific protein blocking was achieved by incubation with 10% normal goat serum; (b) the primary antibody used was a polyclonal rabbit anti-rat fibronectin (Sigma; St Louis, MO); and (c) the secondary antibody used was a biotinylated goat anti-rabbit IgG F(ab)2 fragment (Accurate). Modification of the above procedure for localization of a-smooth muscle actin was as follows: (a) nonspecific protein blocking was achieved by incubation with 10% n o d horse serum; (b) the primary antibody was a monoclonal antibody (MAb) raised against a synthetic decapeptide (Sigma); and (c) the secondary antibody used was a biotinylated horse anti-mouse IgG (Vector). The buffer solution used for rinsing between steps consisted of PBS and 0.05% Tween-20, pH 7.2. Diluent used for both primary and secondary antibodies consisted of PBS, 0.05% Tween-20, and 1% BSA, pH 7.2. After immunostaining, sections were counterstained with Mayer's hematoxylin. Sections were then rinsed, coated with Crystal Mount (Biomeda; Foster City, CA), and permanently mounted with a coverslip using Pro-Tm (American Scientific Products; McGaw Park, E.).
Morphometric Analysis. A section of lung tissue approximately 0.5 x 1.0 cm was analyzed from each of six different animals for each treatment (unexposed control vs asbestos-exposed) at each of two different time points
(1 day and 14 days) after a triple exposure. Each available terminal rcspiratory unit was analyzed, averaging 5-6 bifurcations per slide. Morphometric measurements were made with a Leitz photomicroscope equipped with a video camera and interfaced with a Macintosh IIci computer using the public domain NIH Image software program (written by Wayne Rasband at the National Institutes of Health and available via Intemet or Compuserve and from NTIS, 5285 Port Royal Rd., Springfield, VA 22161).
Six measurements were made for each terminal respiratory unit. For each first alveolar duct bifurcation, both the total area of the bifurcation and the total area of smooth muscle actin staining within the bifurcation were measured. The base of the bifurcation was defined to be delineated by the first lateral alveolar wall to transect the axis ofthe bifurcation. For the purposes of this investigation. the alveolar duct is defined as the airway between the first and second alveolar duct bifurcation. Measurements were made of both the total area of septal tips along one side of the alveolar duct for a given length (0.1742 mm) and the total area of smooth muscle actin staining within the septal tips. Total area ofthe septal tip was delineated by an imaginary line perpendicular to the long axis of the septum and transecting the base of the alveoli on either side of the septum. In addition to septal tips along the alveolar duct, we measured both the total area and the smooth muscle actin-positive area in septal tips along the "respiratory bronchiole." The respiratory bronchiole is a region less well-defined in rats 
Results
Lung tissue from unexposed control animals exhibited minimal staining with the polyclonal TGFP antibody. Staining in tissue from control animals was identical whether tissue was collected at 1 day or at 14 days after the triple exposure. TGFP staining was light and diffuse in cardiac muscle surrounding the pulmonary artery near the hilum. A low level of granular staining was found in some bronchiolar epithelial cells ( Figure 1A ). First alveolar duct bifurcations showed no appreciable staining for TGFP ( Figures 1A and 1B ). Alveolar macrophages, rarely visible, exhibited staining of variable intensity, from no detectable staining to moderately dense ( Figure  IC) . In comparison, lung tissue collected from asbestos-exposed rats 1 day after the triple exposure exhibited many densely stained alveolar macrophages accumulated at alveolar duct bifurcations and scattered in surrounding airways (Figures 1D and IF) . The intensity of macrophage staining was always higher in asbestos-exposed lung than in unexposed controls. Macrophages occurred singly or in clusters and were scattered in the terminal airways or alveolar ducts near a first alveolar duct bifurcation ( Figure 1D ) or, more commonly, were associated with epithelial cells of the bifurcation (Figure lF) . Macrophages rarely were observed in the airways proximal to the terminal bronchiole. At 14 days after the triple exposure, macrophages could still be observed at or near bifurcations, but these macrophages often stained less intensely and were fewer than found in tissue collected at 1 day ( Figure 1G ). Macrophages were observed scattered near bifurcations, either in contact with the surface ofthe bifurcation or within an airway or alveolus nearby. Macrophages occurred singly or in small aggregates, exhibiting a tendency towazds smaller aggregates than were observed at 1 day. TGFP staining was observed along epithelial cells on the surfaces of bifurcations and on some alveolar wall septal tips along the adjacent alveolar duct at 1 and 14 days post exposure ( Figure 1G ). The density of staining in these cells was low and the staining was localized at or near the cell surface ( Figures 1F and 1G ). Specificity of stain-ing was demonstrated by substituting the primary antibody with an IgG fraction of chicken serum at an equivalent titer. Nonspecific background staining with this IgG fraction was minimal ( Figure  1H ). Vascular walls and airway lining cells remained unstained by anti-TGFo in exposed animals. Immunohistochemical localization of fibronectin in lungs of unexposed control animals revealed a genetal distribution throughout the interstitium of the alveolar walls. Connective tissue subtending both airways and vessels exhibited a faint fibrillar staining pattern, indicating the presence of fibronectin within the artmcellular matrix. This staining pattern was also present in larger airways and vessels surrounded by substantial smooth muscle. Blood within vessels exhibited staining for plasma fibronectin. Fibronectin staining at first alveolar duct bifurcations was faint and uniform (Figures 2A and 2B ). Tissue collected from asbestos-exposed animals 1 day after the triple exposure exhibited a distribution of faint fibronectin staining similar to that in unexposed controls. However, the alveolar duct bifurcations were larger in lung tissue from exposed animals than in control animals, and were shown to main more intensely for fibronectin ( Figure 2C ). The staining pattern exhibited a fibrillar to granular pattem, suggesting its presence as an extracellular component of the interstitium. Macrophages associated with alveolar duct bifurcations did not stain positively for fibronectin ( Figure 2C ). Increased fibronectin Staining was o b s e d within the septal tips of the alveolar walls along the alveolar duct adjacent to the first bifurcation ( Figures 2C-2E ). Increased interstitial fibronectin staining was also observed in alveolar duct bifurcations distal to the first bifurcation. In some instances, a general increase in fibronectin staining intensity was observed in the entire terminal respiratory unit surrounding the first alveolar duct bifurcation ( Figures 2D and 2E ). Increased interstitial fibronectin staining was still present 14 days after the triple exposure ( Figure  2F ). The staining pattem was identical to that seen at 1 day post exposure with increased fibronectin at bifurcations and, to a lesser degree, at septal tips. A low level of negligible background staining occurred in the negative control where rabbit semm replaced the primary antibody at the same dilution, thereby c o d i g specific fibronectin staining ( Figure 2G) .
The a-smooth musde actin antibody stained bundles of smooth muscle surrounding airways and vessels in lungs from unexposed controls with great intensity ( Figure 3A) . Smooth musde cells forming the alveolar entrance rings along the alveolar duct were also stained heavily ( Figures 3A and 3B ). This staining pattern was observed at all levels of the alveolar duct from the terminal bronchiole to the extreme peripheral regions ofthe lung. A dump of smooth muscle cells within the alveolar duct bifurcation also exhibited a high degree of staining ( Figure 3B ). Similar patterns of staining were observed in lungs collected at both 1 day (Figures 3C and  3D ) and 14 days ( Figure 3E ) after triple asbestos exposure. Smooth muscle actin staining in alveolar duct septal tips appeared slightly increased in asbestos-exposed lung, with no apparent difference between 1 day and 14 days. Alveolar duct bifurcation smooth muscle actin staining was increased in asbestos-exposed lung but, again, no obvious difference could be observed between 1 day and 14 days. Specificity was demonstrated for this MAb by replacing it with an irrelevant anti-neurofdament protein MAb at an identical dilution.
No positive staining was detected in adjacent sections of rat lung when anti-neurofilament protein was used ( Figure 3F ). Morphometric measurements of total area and smooth muscle actin-positive area were taken at first alveolar duct bifurcations, "respiratory bronchiole" septal tips, and alveolar duct septal Ups. The results are illustrated in Table 1 . The total area of first alveolar duct bifurcations was significantly (p<O.Ol) increased at 1 day after asbestos exposure compared with unexposed controls. The increase in area over unexposed control bifurcations was maintained at 14 days. An increase in smooth muscle actin-positive area was observed at 1 day compared with unexposed control bifurcations and, again, the increase was maintained at 14 days. When the ratio of smooth muscle actin-positive area was compared to total area, no difference was observed between control and asbestos-exposed animals at either time point. Therefore, the ratio of smooth muscle actinpositive area to total bifurcation area is constant. No significant difference was found when either alveolar duct septal tips or "respiratory bronchiole" septal tips were compared with unexposed controls for smooth muscle actin-positive area and total area. Therefore, asbestos exposure did not significantly affect septal tip size or smooth musde actin-positive area. Interestingly, ratios of smooth muscle actin-positive area to total area for both alveolar duct and respiratory bronchiole septal tips were not significantly different from ratios calculated for first alveolar duct bifurcations.
Discussion
Inhalation of chrysotile asbestos fibers causes an accumulation of alveolar macrophages at first alveolar duct bifurcations within 12-24 hr after a single 1-hr exposure (Warheit et al., 1985 (Warheit et al., ,1986 Brody et al., 1981) . During and after the accumulation of macrophages, there is a significant increase in the numbers of proliferating epithelial and mesenchymal cells (McGavran et al., 1990) and the bifurcation size increases. Ultrastructural morphometric data indicate an increase of both epithelial and interstitial cells at the bifurcation as well as an increase in extracellular matrix (Chang et al., 1988) . In the present study, we have shown specific localization of TGFP in the alveolar macrophages accumulating at the first alveolar duct bifurcations ( Figures 1D-1G ). Immunolocalization of TGFP in unexposed control lung tissue also indicated its presence in alveolar macrophages, although the level of staining was never as intense as that found in macrophages of animals exposed to asbestos. Since it has been shown that macrophages produce E F B (Assoian et al., 1987) , the level of staining in alveolar macrophages from lungs of unexposed control animals probably represents the normal constitutive production of TGFP by these cells. Activation and accumulation at sites of fiber deposition apparently increase expression of TGFB in the alveolar macrophages.
The potential mle of macrophage-derived TGFP in pulmonary fibrosis has recently been reviewed . In the bleomycin model of rat pulmonary fibrosis, an increase in both total lung TGFP mRNA (Hoyt and Lazo, 1988) and TGFP production (Khalil et al., 1989) has been shown to precede an increase in both total collagen synthesis (Khald et al., 1989) and, more specifically, collagen I and collagen 111 gene expression (Hoyt and Lato, 1988) . In early bleomycin-induced lesions, TGFP is found mainly in alveolar macrophages, as revealed by immunohistochemical localization (Khalil et al., 1989) . 'EFP was also found in the interstitium, the site of increased collagen synthesis. have proposed a model for the role of TGFP in idiopathic pulmonary fibrosis (IPF) wherein TGFP becomes associated with extracellular matrix after crossing the alveolar epithelium where it can, according to the model, recruit additional inflammatory cells and fibroblasts, thereby initiating the fibrotic lesion. Later stages of IPF are characterized by epithelial cell regeneration and lung remodeling. TGFP is produced by Type I1 pneumocytes and bronchiolar epithelial cells . TGFP produced by these cells in late IPF may inhibit proliferation and promote both differentiation and extracellular matrix production.
We propose a similar role for TGFP in our rat model of asbestosinduced pulmonary fibrosis. Deposition of asbestos fibers on the first alveolar duct bifurcations leads to activation of a complementdependent chemoattractant for alveolar macrophages (Warheit et al., 1985 (Warheit et al., ,1986 . On the basis of the staining pattern shown here, it appears that these macrophages become activated to produce TGFP as they accumulate at sites of fiber deposition, perhaps through phagocytosis of the asbestos fibers (Warheit et al., 1984) . We have shown that asbestos stimulates release of TGFP by lung macrophages in vitro (Kalter and Brody, 1989 ) and that early passage lung fibroblasts have high-affinity receptors for TGFPl and P2 (Kalter and Brody, 1991) . TGFP could act in an autocrine fashion (Van Obberghen-Schilling et al., 1988) , thereby increasing further production of TGFP by macrophages. In addition, TGFP acts as a chemoattractant for macrophages (Wahl et al.. 1987) , possibly for fibroblast recruitment (Osornio-Vargas et al., 1993; Postlethwaite et al., 1987) , and is capable of stimulating proliferation of immature fibroblasts .
TGFP is known to stimulate production of a variety of extracellular matrix components. Specifically, TGFP is capable of stimulating fibroblast synthesis of collagen I (Ignotz and Massague, 1986) , collagen 111 (Varga et al., 1987) , collagen V (Madri et al., 1988) , fibronectin (Roberts and Sporn, 1990) and glycosaminoglycans (Dubaybo and Thet, 1990) . Previous work from our laboratory has shown an increase in extracellular matrix at the ultrastructural level at alveolar duct bifurcations 1 month after a 1-hr asbestos exposure (Chang et al., 1988) . In the present report we have shown a dramatic increase in fibronectin at alveolar duct bifurcations and septal tips along adjacent alveolar duct within 1 day after a triple asbestos exposure. It seems reasonable to postulate that TGFP produced by activated alveolar macrophages at alveolar duct bifurcations acts in a paracrine fashion to stimulate increased fibronectin production by interstitial fibroblasts. Alveolar macrophages are also capable of fibronectin production (Rennard et al., 1981) , although the antibody we used apparently did not stain any of the macrophages associated with the developing lesions ( Figures 2C-2F ).
Low levels oiTGFP staining were found on the surfaces of some alveolar duct bifurcations and neighboring septal tips at 1 and 14 days after triple exposure to asbestos. This staining appeared to be located at or near the apical surface of Type I1 pneumocytes (Figure 1G) . It is possible that Type I1 epithelial cells are producing TGFP after asbestos exposure, similar to that reported in late-stage IPF . TGFP has been localized to extracellular matrix in both bleomycin-induced fibrosis and IPF and has been shown to bind to fibronectin in vitro (Mooradian et al., 1989) . Determining whether or not the alveolar epithelial cells are producing 'EFA which could affect components of the underlying interstitium, is the subject of ongoing studies. Conversely, TGFP produced by alveolar macrophages could be acting to increase fibronectin production by epithelial cells. It is known that epithelial cells are capable of producing and secreting fibronectin in a polarized fashion after stimulation by TGFP (Romberger et al., 1992; Wang et al., 1991) . Therefore, alveolar macrophage-derived TGFP could stimulate interstitial fibronectin production by epithelial cells without actually crossing the epithelial barrier. We know that platelet-derived growth factor is not translocated through an intact alveolar epithelial barrier (Mangum et al., 1990) .
Cells termed "myofibroblasts" exhibit ultrastructural characteristics of both fibroblasts and smooth muscle cells. In the lung, these cells have also been given the term "contractile interstitial cells" (Kapanci et al., 1974) . as they have been shown to possess contractile properties (Evans et al., 1983) . In fibrotic conditions, altered compliance of the lung tissue leads to lung "stiffness" (Karlinksy and Goldstein, 1980) , which is due in part to increases in smooth muscle. This smooth muscle hyperplasia can be rather extensive and in such cases is referred to as "muscular cirrhosis of the lung" (Adler et al., 1986 (Adler et al., ,1989 . A different phenomenon, often confused with smooth muscle hyperplasia, occurs when the contractile interstitial cells proliferate, thereby yielding a lung parenchyma with an increased ability for contraction (see Adler et al., 1989) . Therefore, fibrotic lung may exhibit an altered mechanical compliance as a result of either smooth muscle hyperplasia or proliferation of contractile interstitial cells in addition to increased extracellular matrix production. Studies involving the bleomycin model of rat lung fibrosis have shown a dramatic increase in interstitial myofibroblasts and no change in smooth muscle cells after instillation of bleomycin ( Evans et al., 1982) . Immunohistochemical localization of a-smooth muscle actin in tissue from bleomycin-treated rats showed a dramatic change in the pattem of staining after induction of fibrosis (Mitchell et al., 1989) . There was a dramatic increase in scattered interstitial cells that stained positively for smooth muscle actin within 1 week. Within 4 weeks the lung contained large focal consolidations of interstitial cells staining positively for smooth muscle actin. Therefore, bleomycin causes a fibrotic response characterized by proliferation of interstitial cells that express a musclespecific isoform of actin. It is important to recognize that these cells are probably myofibroblasts, which are generally thought to be of non-muscle origin (Adler et al., 1989; Mitchell et al., 1989) . Whether the increase in smooth muscle actin staining is solely a result of proliferation of smooth muscle actin-positive myofibroblasts or perhaps is partially due to induction of smooth muscle actin expression by existing myofibroblasts is not clear.
We have shown here that the changes in a-smooth muscle actin localization in asbestos-exposed rat lung are confined to the terminal respiratory unit. There is an obvious increase in smooth muscle actin content at the first alveolar duct bifurcations. In addition, smooth muscle actin-positive cells in septal tips along the alveolar duct near the first alveolar duct bifurcation often appeared hypertrophic and hyperplastic. Smooth muscle cells in the septal tips of the alveolar duct have previously been shown to stain positively for a-smooth muscle actin (Mitchell et al., 1989) . and work from our laboratory has shown an increase in myofibroblasts and smooth muscle cells (an increase in both total cell volume and number) 1 month after a 1-hr asbestos exposure (Chang et al., 1988) . We have now shown a signifcant increase in smooth muscle actin 1 day after a 3-day asbestos exposure. The increase in smooth muscle actin staining at bifurcations could be due either to proliferation of smooth muscle cells within bifurcations or to an induction of smooth muscle actin expression by proliferating myofibroblasts, or both. We believe that the density of the staining pattem suggests smooth muscle cells as the site of a-smooth muscle actin, since the cytoplasm of smooth muscle cells would be fded with smooth muscle actin, whereas myofibroblasts only contain a few contractile bundles. An increase in smooth muscle actin localization within alveolar walls, such as that found in the bleomycin model, was not observed after asbestos exposure, since the early lesions of asbestosis are confined to the bronchoalveolar duct regions as described above. It is clear that TGFP and other factors can affect contractile cells and proteins in a variety of cell types (Mitchell et al., 1993) . TGFP has been shown to up-regulate a-smooth muscle actin in cardiac myocytes (Parker et al., 1990) and smooth muscle cells (Bjorkerud, 1991) but not in fibroblasts (Rubbia-Brandt et al., 1991) . It is feasible that the local increase in smooth muscle actin found at first alveolar duct bifurcations could be a result of paracrine stimulation by the E F P produced by alveolar macrophages accumulating on the surfaces of the bifurcations.
In summary, we have shown that exposure to chrysotile asbestos fibers for 5 hr on each of 3 consecutive days leads to alveolar macrophage accumulation and development of a fibrotic lesion at first alveolar duct bifurcations. The alveolar macrophages stain intensely for TGFP within 1 day after the triple exposure and are still present, although reduced in number, after 14 days. A somewhat reduced level of TGFP staining is still seen at the bifurcation after 14 days and is associated with macrophages and alveolar epithelial cells. Localization of fibronectin indicates a dramatic increase of this protein within the extracellular matrix of the bifurcations and within the septal ups along the alveolar duct near the bifurcations by 1 day post exposure, and perhaps to a slightly lesser extent at 14 days. The smooth muscle-specific isoform of actin was shown to localize to the alveolar duct bifurcations where isolated groups of smooth muscle cells are found. Smooth muscle actin was also found in septal tips along the alveolar ducts, where smooth muscle cells are normally found in alveolar entrance rings. A significant increase in smooth muscle actin was found at first alveolar duct bifurcations at both 1 day and 14 days after asbestos exposure. These results support the hypothesis that TGFP, a potent growth factor involved in regulating cell growth and extracellular matrix deposition, is present in macrophages during the pathogenic response to inhalation of fibrogenic chrysotile asbestos. Further work is ongoing using techniques such as Northern analysis and in situ hybridization, which should provide more specific quantitative and qualitative conclusions regarding the involvement of growth factors and the specific cellular mechanisms that mediate this fibrotic response.
